治疗性抗体工程,以有效地针对性地降解 lysosomes 中的膜蛋白
Corentin Gauthier1, Morgane Daurat2, Lamiaa Mohamed Ahmed Ali3
1NanoMedSyn, Montpellier, France; Institut des Biomolécules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France.
概括
在治疗抗体上移植曼6酸盐类似物 (AMFAs) 会增强癌细胞的吸收和目标降解. 这种新的方法显著抑制了癌细胞的增殖,并在临床前模型中提高了治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物运输 药物运输 药物运输
背景情况:
- 针对性降解病态蛋白质是改善单克隆抗体 (mAb) 癌症治疗的关键策略.
- 增强mAb内部化和随后的抗原降解可以提高治疗效果.
研究的目的:
- 研究将曼6酸盐类似物 (AMFA) 植入治疗抗体的疗效.
- 为了确定AMFA结合是否通过曼6酸盐受体 (M6PR) 途径增强抗体内部化.
- 评估AMFA结合对抗原降解,癌细胞增殖和治疗疗效的影响.
主要方法:
- 对AMFA与治疗抗体trastuzumab和cetuximab的结合.
- 在癌细胞中通过M6PR途径对抗体内部化的评估.
- 在AMFA结合后目标抗原降解的量化.
- 在体外对癌细胞增殖抑制的评估.
- 在老鼠和斑马鱼异种移植模型中测试治疗疗效.
主要成果:
- 由于AMFA的结合,M6PR介导的内化作用使得trastuzumab和cetuximab获得了内化作用.
- 与AMFA结合的mAbs显著增加了细胞吸收和增强了抗原的降解.
- 与未结合的抗体相比,结合的mAbs大大抑制了癌细胞的增殖.
- 临床前的异种移植模型显示AMFA结合的mAbs.具有更高的治疗效果.
结论:
- 将AMFA植入治疗mAbs是一个有效的策略,以增强其内部化和目标降解.
- 这项技术在体外和体内显著改善了mAbs的抗癌活性.
- AMFA结合有望改善癌症治疗中的治疗结果.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Lysosomes
17.7K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
17.7K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


